Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pasquale Perrone-Filardi

Showing results (1-10 of 373) with videos related to

Pageof 38
Sort By:
Giornale Italiano Di Cardiologia (2006)|October 8, 2015
[Ezetimibe in clinical practice: from laboratory investigations to the IMPROVE-IT trial results]Claudio Borghi, Pasquale Perrone Filardi
Giornale Italiano Di Cardiologia (2006)|December 23, 2023
[ESC Guidelines for the management of cardiovascular disease in patients with diabetes: what's new?]Furio Colivicchi, Pasquale Perrone Filardi
Giornale Italiano Di Cardiologia (2006)|October 27, 2025
[European guidelines on dyslipidemias: what's new?]Claudio Bilato, Pasquale Perrone Filardi
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|August 4, 2016
"Heart failure, whole-body insulin resistance and myocardial insulin resistance: An intriguing puzzle"Paola Gargiulo, Pasquale Perrone-Filardi
International Journal of Cardiology|February 15, 2016
Reply to: Ezetimibe: A real effect?Gianluigi Savarese, Pasquale Perrone-Filardi
Journal of the American College of Cardiology|April 15, 2014
Reply: benefits of statins in healthy elderly subjects: what is the number needed to treat?Gianluigi Savarese, Pasquale Perrone-Filardi
European Heart Journal|October 12, 2017
Dangerous relationships: aortic stenosis and transthyretin cardiac amyloidosisPaola Gargiulo, Pasquale Perrone-Filardi
Heart Failure Clinics|May 14, 2019
Understanding the Pathophysiology to Improve the Therapeutic Management: Focus on Metabolic and Hormonal Comorbidities in Heart FailurePasquale Perrone Filardi, Eduardo Bossone
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Cardio-renal protection through renin-angiotensin-aldosterone system inhibition: current knowledge and new perspectivesStefania Paolillo, Pasquale Perrone Filardi
Journal of Cardiovascular Development and Disease|January 27, 2026
A Critical Review of the Molecular and Clinical Effects of Cilostazol After Percutaneous Coronary InterventionRoberto Ferrari, Pasquale Perrone Filardi
Pageof 38

Showing results (1-10 of 373) with videos related to

Sort By:
Pageof 38
Giornale Italiano Di Cardiologia (2006)|October 8, 2015
[Ezetimibe in clinical practice: from laboratory investigations to the IMPROVE-IT trial results]Claudio Borghi, Pasquale Perrone Filardi
Giornale Italiano Di Cardiologia (2006)|December 23, 2023
[ESC Guidelines for the management of cardiovascular disease in patients with diabetes: what's new?]Furio Colivicchi, Pasquale Perrone Filardi
Giornale Italiano Di Cardiologia (2006)|October 27, 2025
[European guidelines on dyslipidemias: what's new?]Claudio Bilato, Pasquale Perrone Filardi
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|August 4, 2016
"Heart failure, whole-body insulin resistance and myocardial insulin resistance: An intriguing puzzle"Paola Gargiulo, Pasquale Perrone-Filardi
International Journal of Cardiology|February 15, 2016
Reply to: Ezetimibe: A real effect?Gianluigi Savarese, Pasquale Perrone-Filardi
Journal of the American College of Cardiology|April 15, 2014
Reply: benefits of statins in healthy elderly subjects: what is the number needed to treat?Gianluigi Savarese, Pasquale Perrone-Filardi
European Heart Journal|October 12, 2017
Dangerous relationships: aortic stenosis and transthyretin cardiac amyloidosisPaola Gargiulo, Pasquale Perrone-Filardi
Heart Failure Clinics|May 14, 2019
Understanding the Pathophysiology to Improve the Therapeutic Management: Focus on Metabolic and Hormonal Comorbidities in Heart FailurePasquale Perrone Filardi, Eduardo Bossone
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Cardio-renal protection through renin-angiotensin-aldosterone system inhibition: current knowledge and new perspectivesStefania Paolillo, Pasquale Perrone Filardi
Journal of Cardiovascular Development and Disease|January 27, 2026
A Critical Review of the Molecular and Clinical Effects of Cilostazol After Percutaneous Coronary InterventionRoberto Ferrari, Pasquale Perrone Filardi
Pageof 38